What is the share price of Fortis Healthcare Ltd (FORTIS) today?
The share price of FORTIS as on 28th August 2026 is ₹926.75. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Fortis Healthcare Ltd (FORTIS) share?
The past returns of Fortis Healthcare Ltd (FORTIS) share are- Past 1 week: 1.06%
- Past 1 month: -1.50%
- Past 3 months: -3.11%
- Past 6 months: -0.16%
- Past 1 year: 2.16%
- Past 3 years: 180.35%
- Past 5 years: 225.88%
What are the peers or stocks similar to Fortis Healthcare Ltd (FORTIS)?
The peers or stocks similar to Fortis Healthcare Ltd (FORTIS) include:What is the dividend yield % of Fortis Healthcare Ltd (FORTIS) share?
The current dividend yield of Fortis Healthcare Ltd (FORTIS) is 0.11.What is the market cap of Fortis Healthcare Ltd (FORTIS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fortis Healthcare Ltd (FORTIS) is ₹68482.25 Cr as of 28th August 2026.What is the 52 week high and low of Fortis Healthcare Ltd (FORTIS) share?
The 52-week high of Fortis Healthcare Ltd (FORTIS) is ₹1104.30 and the 52-week low is ₹766.80.What is the PE and PB ratio of Fortis Healthcare Ltd (FORTIS) stock?
The P/E (price-to-earnings) ratio of Fortis Healthcare Ltd (FORTIS) is 65.74. The P/B (price-to-book) ratio is 6.73.Which sector does Fortis Healthcare Ltd (FORTIS) belong to?
Fortis Healthcare Ltd (FORTIS) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Fortis Healthcare Ltd (FORTIS) shares?
You can directly buy Fortis Healthcare Ltd (FORTIS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Fortis Healthcare Ltd
FORTIS Share Price
NSEFORTIS Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
FORTIS Performance & Key Metrics
FORTIS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 65.35 | 6.73 | 0.11% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.42 | 5.95 | 0.50% |
from 20 analysts
Price Upside
Earnings Growth
Rev. Growth
FORTIS Company Profile
Fortis Healthcare Limited is an integrated healthcare delivery service provider. The Company is engaged in establishing, administering hospitals, diagnostic centers and research centers.
FORTIS Sentiment Analysis
FORTIS Sentiment Analysis
FORTIS Stock Summary · May 2026
Strong FY26 top‑line and margin expansion anchored the call: consolidated revenue reached INR 9,128 crore while operating EBITDA rose 31.3% to INR 2,085 crore, reflecting improving profitability. Management struck an assertive but pragmatic tone, emphasizing disciplined capacity expansion—roughly 800 beds added via brownfield and acquisitions—continued investments in diagnostics capabilities and an internal digital platform, and a stated target to reach a 25% consolidated operating EBITDA margin by FY28 with steady ~1.5%–2.0% annual margin improvement. They flagged upside levers as occupancy gains, brownfield scale and turnarounds of loss‑making units, but acknowledged tensions from a slight occupancy dip to 68% despite a ~15% rise in occupied beds, regional regulatory and pricing pressures (CGHS/ECHS circular, oncology price caps) and softer international volumes, which have localized impact. Balance sheet effects of acquisitions were noted—net debt at INR 2,334 crore—and management reiterated FY27 guidance is organic: hospital revenue growth targeted at 15%+ with ~150 bps EBITDA uplift, diagnostics margin to 23%–24%, and FY27 capex guidance around INR 900 crore.
FORTIS Stock Growth Drivers
FORTIS Stock Growth Drivers
6Robust Financial Performance and Shareholder Returns
The company delivered materially stronger FY26 financials with consolidated revenues of INR 9,128 crore (up
High‑Value Specialty Mix and ARPOB/Upsell Gains
Hospital revenues are being driven by an increasing contribution from focus specialties—Oncology, Neurosciences, Cardiac, Gastroenterology,
FORTIS Stock Challenges
FORTIS Stock Challenges
5Rising leverage and near‑term cash deployment risk
Net debt increased to INR 2,334 crores and net‑debt‑to‑EBITDA rose to 1.09x (from 0.93 a
Occupancy and revenue pressure driven by payer mix and international volume declines
Several large hospitals have experienced declining occupancy driven by a meaningful slowdown in international patient
FORTIS Forecast
FORTIS Forecasts
Price
Revenue
Earnings
FORTIS Share Price Forecast
FORTIS Share Price Forecast
All values in ₹
All values in ₹
FORTIS Company Revenue Forecast
FORTIS Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
FORTIS Stock EPS (Earnings Per Share) Forecast
FORTIS Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
FORTIS
FORTIS
Income
Balance Sheet
Cash Flow
FORTIS Income Statement
FORTIS Income Statement
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,803.14 | 1,872.70 | 2,005.86 | 1,975.01 | 2,031.64 | 2,197.67 | 2,381.23 | 2,276.83 | 2,375.28 | 2,573.41 | ||||||||||
| Operating & Other expenses | 1,404.84 | 1,516.38 | 1,613.33 | 1,553.14 | 1,625.30 | 1,676.05 | 1,775.11 | 1,805.27 | 1,844.83 | 2,007.91 | ||||||||||
| EBITDA | 398.30 | 356.32 | 392.53 | 421.87 | 406.34 | 521.62 | 606.12 | 471.56 | 530.45 | 565.50 | ||||||||||
| Depreciation/Amortization | 92.23 | 91.00 | 95.05 | 97.33 | 102.23 | 101.48 | 105.84 | 120.14 | 121.97 | 121.88 | ||||||||||
| PBIT | 306.07 | 265.32 | 297.48 | 324.54 | 304.11 | 420.14 | 500.28 | 351.42 | 408.48 | 443.62 | ||||||||||
| Interest & Other Items | 34.69 | 35.27 | 36.43 | 45.15 | 67.56 | 69.57 | 74.88 | 85.74 | 84.28 | 80.44 | ||||||||||
| PBT | 271.38 | 230.05 | 261.05 | 279.39 | 236.55 | 350.57 | 425.40 | 265.68 | 324.20 | 363.18 | ||||||||||
| Taxes & Other Items | 92.65 | 64.09 | 84.59 | 31.49 | 52.66 | 90.29 | 103.48 | 71.95 | 58.35 | 96.79 | ||||||||||
| Net Income | 178.73 | 165.96 | 176.46 | 247.90 | 183.89 | 260.28 | 321.92 | 193.73 | 265.85 | 266.39 | ||||||||||
| EPS | 2.37 | 2.20 | 2.34 | 3.28 | 2.44 | 3.45 | 4.26 | 2.57 | 3.52 | 3.53 |
FORTIS Company Updates
Investor Presentation
FORTIS Stock Peers
FORTIS Past Performance & Peer Comparison
FORTIS Past Performance & Peer Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Fortis Healthcare Ltd | 65.74 | 6.73 | 0.11% |
| Apollo Hospitals Enterprise Limited | 64.37 | 12.52 | 0.23% |
| Max Healthcare Institute Limited | 67.48 | 9.06 | 0.20% |
| Manipal Health Enterprises Limited | 105.44 | 10.69 | — |
FORTIS Stock Price Comparison
Compare FORTIS with any stock or ETFFORTIS Holdings
FORTIS Shareholdings
FORTIS Promoter Holdings Trend
FORTIS Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
FORTIS Institutional Holdings Trend
FORTIS Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
FORTIS Shareholding Pattern
FORTIS Shareholding Pattern
FORTIS Shareholding History
FORTIS Shareholding History
Mutual Funds Invested in FORTIS
Mutual Funds Invested in FORTIS
No mutual funds holding trends are available
Top 5 Mutual Funds holding Fortis Healthcare Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 4.4712% | Percentage of the fund’s portfolio invested in the stock 2.91% | Change in the portfolio weight of the stock over the last 3 months -0.24% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 8/82 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 3.8773% | Percentage of the fund’s portfolio invested in the stock 3.83% | Change in the portfolio weight of the stock over the last 3 months -0.25% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 1/74 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.8887% | Percentage of the fund’s portfolio invested in the stock 2.55% | Change in the portfolio weight of the stock over the last 3 months -0.21% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 6/106 (-3) |
Compare 3-month MF holding change on Screener
smallcases containing FORTIS stock
smallcases containing FORTIS stock
Looks like this stock is not in any smallcase yet.
FORTIS Events
FORTIS Events
FORTIS Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
FORTIS Dividend Trend
No dividend trend available
FORTIS Upcoming Dividends
FORTIS Upcoming Dividends
No upcoming dividends are available
FORTIS Past Dividends
FORTIS Past Dividends
Cash Dividend
Ex DateEx DateJul 24, 2026
Dividend/Share
₹1.00
Ex DateEx Date
Jul 24, 2026
Cash Dividend
Ex DateEx DateJul 25, 2025
Dividend/Share
₹1.00
Ex DateEx Date
Jul 25, 2025
Cash Dividend
Ex DateEx DateJul 24, 2024
Dividend/Share
₹1.00
Ex DateEx Date
Jul 24, 2024
Cash Dividend
Ex DateEx DateJul 20, 2023
Dividend/Share
₹1.00
Ex DateEx Date
Jul 20, 2023
FORTIS Stock News & Opinions
FORTIS Stock News & Opinions
Fortis Healthcare Ltd share price inched up 1.02% to Rs 935.0 after the company's net profit saw a mild growth of 0.59% to Rs 272.8 crore, while revenue from operations improved marginally 7.63% to Rs 2545.03 crore in Q2FY26 over Q1FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.11 lakh crore, rising 5.20%. It has edged up by 13.41% over last one week and rallied by 31.33% in last one month while the market capitalization of Fortis Healthcare Ltd has slipped by 1.42% and 1.80% in the same period respectively. Profit before tax (PBT) of Fortis Healthcare Ltd stood at Rs 363.18 crore in Q2 FY26, gaining 3.60% year-on-year, and climbing 12.02% quarter-on-quarter. EBITDA came in at Rs 523 crore, easing 9.97% YoY and declining 1.00% sequentially. Total expenses saw a slight increase of 8.98% to Rs 2129.79 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 585.57 crore, increasing 12.45% YoY, while employee benefits expense was at Rs 404.43 crore, soaring 19.06% YoY. For the TTM ended FY26, revenue from operations rose 17.28% to Rs 9127.84 crore, while net profit soared by 31.48% to Rs 1064.19 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 158382% to Rs 2034.32 crore, and PBT witnessed a strong rise of 35.63% to Rs 1365.85 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 1601.46 crore in FY26, as against Rs 1423.93 crore in FY25. Fortis Healthcare Ltd headed higher 6.71% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.64% during the same period.
Fortis Healthcare Limited will hold a board meeting on Thursday, August 06, 2026, to consider and approve the unaudited financial results (standalone & consolidated) for the quarter ended June 30, 2026, according to a regulatory filing. The company also announced that the trading window for dealing in securities will remain closed until August 08, 2026, following a previous announcement on June 24, 2026.
Fortis Healthcare has fixed 24 July 2026 as record date for payment of final dividend for FY 2026.
Fortis Healthcare announced that the Annual General Meeting(AGM) of the company will be held on 11 August 2026.
Fortis Healthcare announced that the Board of Directors of the Company at its meeting held on 22 May 2026, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.
Net profit of Fortis Healthcare rose 44.57% to Rs 265.85 crore in the quarter ended March 2026 as against Rs 183.89 crore during the previous quarter ended March 2025. Sales rose 17.81% to Rs 2364.67 crore in the quarter ended March 2026 as against Rs 2007.20 crore during the previous quarter ended March 2025. For the full year,net profit rose 34.56% to Rs 1041.78 crore in the year ended March 2026 as against Rs 774.21 crore during the previous year ended March 2025. Sales rose 17.28% to Rs 9127.84 crore in the year ended March 2026 as against Rs 7782.75 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales2364.672007.20 18 9127.847782.75 17 OPM %22.5121.70 -22.8420.40 - PBDT458.66392.35 17 1837.521481.99 24 PBT336.69290.12 16 1388.091096.38 27 NP265.85183.89 45 1041.78774.21 35 Powered by Capital Market - Live
Fortis Healthcare will hold a meeting of the Board of Directors of the Company on 22 May 2026.
Net profit of Fortis Healthcare declined 21.85% to Rs 193.73 crore in the quarter ended December 2025 as against Rs 247.90 crore during the previous quarter ended December 2024. Sales rose 17.46% to Rs 2265.01 crore in the quarter ended December 2025 as against Rs 1928.26 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales2265.011928.26 17 OPM %22.3219.45 - PBDT431.73352.92 22 PBT311.59255.59 22 NP193.73247.90 -22 Powered by Capital Market - Live
Fortis Healthcare will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live
Fortis Healthcare announced that its wholly owned subsidiary, International Hospital on 19 December 2025 has signed definitive agreements for acquisition of TMI Healthcare (primarily comprises hospital operations) through a share purchase agreement and acquisition of the underlying hospital land and building, and the adjacent land thereto (Proposed Transaction). The acquisition will enable the company to expand, scale up and deliver quality healthcare services to patients in Bengaluru. TMI Healthcare comprises the People Tree Hospital, Yeshwanthpur and two identified facilities (People Tree Hospital, Raghavendra and People Tree Hospital, Meenakshi). As part of the transaction to acquire 100% equity stake in TMI Healthcare; the above identified facilities would be carved out from TMI Healthcare prior to transaction closure. In addition to the acquisition of TMI Healthcare, IHL is also acquiring the underlying land and hospital building and an adjacent land parcel.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 17.64%, vs industry avg of 18.04%
Over the last 5 years, market share decreased from 9.69% to 9.31%